1/1
6 files

Supplementary Tables – Impact of fast-track regulatory designations on strategic commercialisation decisions for autologous cell therapies

dataset
posted on 25.01.2022, 08:51 by Figshare Future Science GroupFigshare Future Science Group, Ching Lam, Edward Meinert, Aidong Yang, Zhanfeng Cui

Supplementary Material 1. Early-access designations in the US, EU, Japan and China

Supplementary Material 3. Distance between cities in miles

Supplementary Material 5. Case study parameters

Supplementary Material 6. Facility parameters

Supplementary Material 7. Equipment

Supplementary Material 8. Additional parameters

Funding

CRMI Technology Centre at the University of Oxford

History